Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01307891Phase 2Completed
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
Breast CancerMetastatic Breast CancerStage IV Breast Cancer+1 more
Principalinvestigator

Research Network

Collaboration Network

10 collaborators·24 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Antoni Ribas, MD

University of California, Los Angeles

Related
2 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Agop Y. Bedikian, MD

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Lee Cranmer, M.D.

University of Arizona

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

John Kirkwood, M.D.

University of Pittsburgh

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Steven J. O'Day, M.D.

Cancer Institute Medical Group, Inc.

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Colin P. Curran, M.D.

Palmetto Hematology Oncology, P.C.

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Breast CancerMetastatic Breast CancerTriple Negative Breast Neoplasms
Similarity Score15%

David S Schrump, M.D.

National Cancer Institute (NCI)

Related
21 trials

Shared therapeutic areas:

MelanomaBreast CancerNeoplasm Metastasis
Similarity Score15%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Breast CancerStage IV Breast CancerTriple Negative Breast Neoplasms
Similarity Score15%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast CancerNeoplasm Metastasis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00099970Phase 2PrincipalInvestigator

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

MelanomaMetastases
Completed
NCT01307891Phase 2PrincipalInvestigator

Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer

Breast CancerMetastatic Breast CancerStage IV Breast Cancer+1 more
Completed

All 2 trials loaded